Actions of sulfasalazine and 5-aminosalicylic acid as reactive oxygen scavengers in the suppression of bile acid-induced increases in colonic epithelial cell loss and proliferative activity

|

|

Summary

This summary is machine-generated.

Sulfasalazine and its metabolite 5-aminosalicylic acid protect the colon by reducing cell damage and proliferation. They counteract reactive oxygen species, suggesting a key role in treating inflammatory bowel disease.

Area Of Science

  • Gastroenterology
  • Pharmacology
  • Cell Biology

Background

  • Ulcerative colitis involves mucosal injury, and sulfasalazine's mechanism is unclear.
  • Sodium deoxycholate induces colonic epithelial cell loss and increased proliferation in a rat model.

Purpose Of The Study

  • To investigate the protective mechanism of sulfasalazine against colonic mucosal injury.
  • To determine the role of reactive oxygen species in sulfasalazine's therapeutic action.

Main Methods

  • Rats received intracolonic sodium deoxycholate to induce injury.
  • Effects of sulfasalazine, 5-aminosalicylic acid, and sulfapyridine on DNA loss, ornithine decarboxylase, and thymidine incorporation were measured.
  • In vitro reactive oxygen formation was assessed using colonic mucosal scrapings.

Main Results

  • Sulfasalazine and 5-aminosalicylic acid reduced DNA loss and increased proliferation induced by sodium deoxycholate.
  • Both compounds also inhibited xanthine-xanthine oxidase-induced responses.
  • Sodium deoxycholate increased reactive oxygen species, an effect blocked by sulfasalazine and 5-aminosalicylic acid, but not sulfapyridine.

Conclusions

  • Sulfasalazine and its active metabolite 5-aminosalicylic acid protect against colonic mucosal injury.
  • Their ability to scavenge reactive oxygen species is a likely mechanism for their therapeutic effects in inflammatory bowel disease.

Related Concept Videos